Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1968 Jul;33(3):501–512. doi: 10.1111/j.1476-5381.1968.tb00498.x

Some pharmacodynamic properties of cellulose sulphate, a kininogen-depleting agent in the rat.

A M Rothschild
PMCID: PMC1570239  PMID: 4178154

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTRUP T., MULLERTZ S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys. 1952 Oct;40(2):346–351. doi: 10.1016/0003-9861(52)90121-5. [DOI] [PubMed] [Google Scholar]
  2. DINIZ C. R., CARVALHO I. F. A micromethod for determination of bradykininogen under several conditions. Ann N Y Acad Sci. 1963 Feb 4;104:77–89. doi: 10.1111/j.1749-6632.1963.tb17654.x. [DOI] [PubMed] [Google Scholar]
  3. EISEN V. FIBRINOLYSIS AND FORMATION OF BIOLOGICALLY ACTIVE POLYPEPTIDES. Br Med Bull. 1964 Sep;20:205–209. doi: 10.1093/oxfordjournals.bmb.a070332. [DOI] [PubMed] [Google Scholar]
  4. Gautvik K. M., Rugstad H. E. Kinin formation and kininogen depletion in rats after intravenous injection of ellagic acid. Br J Pharmacol Chemother. 1967 Nov;31(3):390–400. doi: 10.1111/j.1476-5381.1967.tb00406.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HAMBERG U., ROCHA E., SILVA M. Release of bradykinin as related to the esterase activity of trypsin and of the venom of Bothrops jararaca. Experientia. 1957 Dec 15;13(12):489–490. doi: 10.1007/BF02159413. [DOI] [PubMed] [Google Scholar]
  6. IATRIDIS S. G., FERGUSON J. H. Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system. J Clin Invest. 1962 Jun;41:1277–1287. doi: 10.1172/JCI104590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. KIMURA E. T., YOUNG P. R., STEIN R. J., RICHARDS R. K. Some pharmacologic characteristics of hexadimethrine bromide (polybrene); a new antiheparin agent. Toxicology. 1959 Mar;1(2):185–202. doi: 10.1016/0041-008x(59)90139-5. [DOI] [PubMed] [Google Scholar]
  8. MCGILVERY R. W., MOKRASCH L. C. Purification and properties of fructose-1, 6-diphosphatase. J Biol Chem. 1956 Aug;221(2):909–917. [PubMed] [Google Scholar]
  9. ROBINSON D. S., HARRIS P. M., RICKETTS C. R. The production of lipolytic activity in rat plasma after the intravenous injection of dextran sulphate. Biochem J. 1959 Feb;71(2):286–292. doi: 10.1042/bj0710286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. ROCHA E SILVA M., ROTHSCHILD A. M. Anaphylatoxin, histamine depletion and skin reactions in the rat. Nature. 1955 Jun 4;175(4466):987–988. doi: 10.1038/175987b0. [DOI] [PubMed] [Google Scholar]
  11. ROCHA e SILVA M. The role played by leucocytes and platelets in anaphylactic and peptone shock. Ann N Y Acad Sci. 1950 Apr 28;50(9):1045–1067. doi: 10.1111/j.1749-6632.1950.tb39902.x. [DOI] [PubMed] [Google Scholar]
  12. Rothschild A. M., Castania A. Endotoxin shock in dogs pretreated with cellulose sulphate, an agent causing partial plasma kininogen depletion. J Pharm Pharmacol. 1968 Jan;20(1):77–78. doi: 10.1111/j.2042-7158.1968.tb09628.x. [DOI] [PubMed] [Google Scholar]
  13. Rothschild A. M., Gascon L. A. Sulphuric esters of polysaccharides as activators of a bradykinin-forming system in plasma. Nature. 1966 Dec 17;212(5068):1364–1364. doi: 10.1038/2121364a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES